Skip to content

Banned / Annex II

apomorphine

CAS 58-00-4
3

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

Apomorphine — a prescription dopamine-agonist drug for Parkinson disease. Banned from EU cosmetics under Annex II; pharmaceutical-only, not a skincare ingredient.

Skin benefits

  • No cosmetic use; prescription Parkinson disease drug

Known concerns

  • EU Cosmetics Regulation Annex II — banned
  • Potent dopamine receptor agonist prescription drug
  • Severe systemic effects: nausea, hypotension, hallucinations
  • Should never appear in any cosmetic product

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Related banned / annex iis

3
Adonis vernalis L. and its preparations
Banned / Annex II
 3
Anamirta cocculus L. (fruit)
Banned / Annex II
 3
Atropa belladonna L. and its preparations
Banned / Annex II
 3
Prunus laurocerasus L. ("cherry laurel water")
Banned / Annex II
 3
Rauwolfia serpentia L., alkaloids and their salts
Banned / Annex II
 2
MERCURIC OXIDE
Banned / Annex II
 1
Benzo[j]fluoranthene
Banned / Annex II
 1
Benzo[k]fluoranthene
Banned / Annex II

Check your shelf

Find apomorphine in your products.

Scan any cosmetic product with LuxSense to see if it contains apomorphine and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.